143
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Modulating effect of Withania somnifera on TCA cycle enzymes and electron transport chain in azoxymethane-induced colon cancer in mice

, , , &
Pages 523-527 | Received 09 Dec 2009, Accepted 24 Dec 2009, Published online: 05 Feb 2010

References

  • Jemal, A., Tiwari, R.C., Murray, T, et al. Cancer statistics. CA. Cancer J. Clin. 2004, 54, 8–29.
  • Sinha, R., Anderson, D.E., McDonald, S.S., Greenwald, P. Cancer risk and diet in India. J. Postgrad. Med. 2003, 49, 222–228.
  • Diwan, B.A., Blackman, K.E. Differential susceptibility of 3 sublines of C57BL/6 mice to the induction of colorectal tumors by 1,2-dimethylhydrazine. Cancer Lett. 1980, 9, 111–115.
  • Nambiar, P.R., Girnun, G., Lillo, N.A., Guda, K., Whiteley, H.E., Rosenberg, D.W. Preliminary analysis of azoxymethane induced colon tumors in inbred mice commonly used as transgenic/knockout progenitors. Int. J. Oncol. 2003, 22, 145–150.
  • Papanikolaou, A., Wang, Q.S., Delker, D.A., Rosenberg, D.W. Azoxymethane-induced colon tumors and aberrant crypt foci in mice of different genetic susceptibility. Cancer Lett. 1998, 130, 29–34.
  • Madara, J.L., Harte, P., Deasy, J., Ross, D., Lahey, S., Steele, G., Jr. Evidence for an adenoma-carcinoma sequence in dimethylhydrazine-induced neoplasms of rat intestinal epithelium. Am. J. Pathol. 1983, 110, 230–235.
  • Takahashi, M., Nakatsugi, S., Sugimura, T., Wakabayashi, K. Frequent mutations of the beta catenin gene in mouse colon tumors indued by azoxy methane. Carcinogenesis. 1983, 21, 1117–1120.
  • Bird, R.P. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett. 1987, 37, 147–151.
  • Papanikolaou, A., Wang, Q.S., Papanikolaou, D., Whiteley, H.E., Rosenberg, D.W. Sequential and morphological analyses of aberrant crypt foci formation in mice of differing susceptibility to azoxymethane-induced colon carcinogenesis. Carcinogenesis. 2000, 21, 1567–1572.
  • Siu, I.M., Pretlow, T.G., Amini, S.B., Pretlow, T.P. Identification of dysplasia in human colonic aberrant crypt foci. Am. J. Pathol. 1997, 150, 1805–1813.
  • Bolt, A.B., Papanikolaou, A., Delker, D.A., Wang, Q.S., Rosenberg, D.W. Azoxymethane induces KI-ras activation in the tumor resistant AKR/J mouse colon. Mol. Carcinogen. 2000, 27, 210–218.
  • Pretlow, T.P., Brasitus, T.A., Fulton, N.C., Cheyar, C., Kaplan, E.L., Ras, K. Mutations in putative preneoplastic lesions in human colon. J. Natl. Cancer Inst. 1994, 85, 2004–2007.
  • Jen, J., Powell, S.M., Papadopoulos, N., et al. Molecular determinants of dysplasia in colorectal lesions. Cancer Res. 1994, 54, 5523–5526.
  • Charaka, S. (1949). Sree Bulab Kunvera Ayurvedic Society, India.
  • Sharma, K., Dandiaya, P.C. Withania somnifera dunal-present status. Indian Drugs. 1992, 29, 247–253.
  • Ziauddin, M., Phansalkar, N., Patki, P., Diwanay, S., Patwardhan, B. Studies on the immunomodulatory effects of Ashwagandha. J. Ethnopharmacol. 1996, 50, 69–76.
  • Weige, C.C., Allred, K.F., Allred, C.D. Estradiol alters cell growth in nonmalignant colonocytes and reduces the formation of preneoplastic lesions in the colon. Cancer Res. 2009, 69, 9118–9124.
  • Schmid, S.A., Dietrich, A., Schulte, S., Gaumann, A., Kunz-Schughart, L.A. Fibroblastic reaction and vascular maturation in human colon cancers. Int. J. Radiat. Biol. 2009, 85, 1013–1025.
  • Majumdar, A.P., Banerjee, S., Nautiyal, J., et al. Curcumin synergizes with resveratrol to inhibit colon cancer. Nutr. Cancer. 2009, 61, 544–553.
  • Rao, C.V., Steele, V.E., Swamy, M.V., Patlolla, J.M., Guruswamy, S., Kopelovich, L. Inhibition of azoxymethane-induced colorectal cancer by CP-31398, a TP53 modulator, alone or in combination with low doses of celecoxib in male F344 rats. Cancer Res. 2009, 69, 8175–8182.
  • Johnson, D. Effective diet counseling begins early in hospitalization. Hospitals. 1967, 41, 94–100.
  • King, J. Practical Clinical Enzymology. London: D. van Nostrand Co., 1965, pp 83–93.
  • Mehler, A.H., Kornberg, A. The enzymatic mechanism of oxidation-reductions between malate or isocitrate and pyruvate. J. Biol. Chem. 1948, 174, 961–977.
  • Birch-Maching, M.A., Brigss, H.L., Saborida, A.A., Bingoff, L.A., Tumbull, D.M. An evaluation of measurement of the activities of complexes I-IV in respiratory chain of human skeletal muscle mitochondria. Biol. Chem. Med. Metab. Biol. 1994, 51, 35–42.
  • Capaldi, R.A., Maruschi, M.F., Taanman, J.W. Mammalian cytochrome C oxidase: characterization of enzymes and immunological detection of subunits in tissue extracts and whole cells. Methods Biochem. Anal. 1995, 2, 427–434.
  • Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193, 265–275.
  • Pederson, P.L. Tumor mitochondria and bioenergetics of the cancer cells. Prog. Exp. Tumor Res. 1978, 22, 190–274.
  • Arigiles, J.M., Bieto, J.A. The metabolic environment of cancer. Mol. Cell. Biochem. 1998, 81, 3–17.
  • Boveris, A., Chance, B. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem. J. 1973, 134, 707–716.
  • Enns, G.M. The contribution of mitochondria to common disorders. Mol. Genet. Metab. 2003, 80, 11–26.
  • Thirunavukkarasu, C., Singh, J.P., Selvendiran, K., Sakthisekaran, D. Chemopreventive efficacy of selenium against N-nitrosodiethylamine-induced hepatoma in albino rats. Cell Biochem. Funct. 2001, 19, 265–271.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.